C/ BASE NO CPA SPMS 2025/1303 - TRASTUZUMAB DERUXTECANO 100 MG PÓ CONC SOL INJ FR IV
TED · 757372-2026Award noticeawardedNo deadline given
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde de Coimbra, EPE in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| Brainlab Sales GmbH | 2 | €2,619,329 | 2026-10-08 |
| Cencora 3PL Portugal, S.A. | 2 | €1,435,097 | 2026-10-28 |
| ROCHE FARMACÊUTICA QUÍMICA, LDA. | 2 | €1,240,039 | 2026-10-29 |
| Cencora 3Pl Portugal, S.A. | 2 | €823,396 | 2026-10-27 |
| Roche Farmacêutica Química, Lda. | 2 | — | 2026-10-08 |
Full buyer profile: what Unidade Local de Saúde de Coimbra, EPE buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Aquisição de Trastuzumab deruxtecano 100 mg Pó conc sol inj Fr IV
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-07-07 | 2025/1303 - TRASTUZUMAB DERUXTECANO [100 MG PÓ CONC SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 96% |
| 2026-09-17 | C/ BASE NO CPA 2025_1746 - TREPROSTINILO 10 MG/ML SOL INJ FR 10 ML IV SC | Unidade Local de Saúde de Coimbra, EPE PT | 95% |
| 2026-10-28 | C/ BASE NO CPA 2026_6 | Unidade Local de Saúde de Coimbra, EPE PT | 95% |
| 2026-10-08 | C/ BASE NO CPA 2025_1303 - OCRELIZUMAB 920 MG/23 ML SOL INJ FR 23 ML SC | Unidade Local de Saúde de Coimbra, EPE PT | 94% |
| 2026-09-22 | 2023/0491 - TRASTUZUMAB EMTANSINA [100 MG PÓ CONC SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 94% |
| 2026-10-08 | C/ BASE NO CPA 2025_1589 - AMIVANTAMAB 1600 MG/10 ML+AMIVANTAMAB 2240 MG | Unidade Local de Saúde de Coimbra, EPE PT | 94% |